Dyspnea Threshold During 6 Minutes Walk Test
SD6
Self-perception of Dyspnea Threshold During the 6-minute Walk Test (DT6): A New Tool for Individualized Exercise Training With Chronic Obstructive Pulmonary Disease Patients (COPD)
1 other identifier
interventional
82
1 country
1
Brief Summary
In view of the multiple limitations and restrictions relative to CPET (technical, time, physical…), determination of individualized training threshold from this evaluation is today not possible for a lot of patients. The aim of this study was to propose a new clinical tool from 6MWT for individualized exercise training: the dyspnea threshold (DT6).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 4, 2014
CompletedFirst Posted
Study publicly available on registry
March 10, 2014
CompletedMarch 10, 2014
March 1, 2014
2 months
March 4, 2014
March 6, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of heart rate between 1st and 2nd 6MWT
at baseline (2 days after entry in pulmonary rehabilitation)
Secondary Outcomes (1)
Change of heart rate between VT (CPET) and DT6 (6MWT)
At baseline
Study Arms (1)
COPD patient
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- COPD
- with or without rest and/or ambulation oxygen therapy
You may not qualify if:
- exacerbation in the previous four weeks
- with a restrictive or mixed respiratory syndrome, angina , recent heart attack (\< 1 month) or coronary progressive pathology
- under beta-blockers
- cognitive or motor problems which limit significantly comprehension or achievement of evaluations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- 5 Santélead
Study Sites (1)
Clinique du Souffle La Vallonie
Lodève, 34700, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Nelly HERAUD
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2014
First Posted
March 10, 2014
Study Start
January 1, 2014
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
March 10, 2014
Record last verified: 2014-03